Literature DB >> 25613589

Menstrual cycle effects on psychological symptoms in women with PTSD.

Yael I Nillni1, Suzanne L Pineles, Samantha C Patton, Matthew H Rouse, Alice T Sawyer, Ann M Rasmusson.   

Abstract

The menstrual cycle has been implicated as a sex-specific biological process influencing psychological symptoms across a variety of disorders. Limited research exists regarding the role of the menstrual cycle in psychological symptoms among women with posttraumatic stress disorder (PTSD). The current study examined the severity of a broad range of psychological symptoms in both the early follicular (Days 2-6) and midluteal (6-10 days postlutenizing hormone surge) phases of the menstrual cycle in a sample of trauma-exposed women with and without PTSD (N = 49). In the sample overall, total psychological symptoms (d = 0.63), as well as depression (d = 0.81) and phobic anxiety (d = 0.81) symptoms, specifically, were increased in the early follicular compared to midluteal phase. The impact of menstrual cycle phase on phobic anxiety was modified by a significant PTSD × Menstrual Phase interaction (d = 0.63). Women with PTSD reported more severe phobic anxiety during the early follicular versus midluteal phase, whereas phobic anxiety did not differ across the menstrual cycle in women without PTSD. Thus, the menstrual cycle appears to impact fear-related symptoms in women with PTSD. The clinical implications of the findings and future research directions are discussed. Published 2015. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2015        PMID: 25613589     DOI: 10.1002/jts.21984

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  28 in total

1.  Methods to reduce false reporting of substance abstinence in clinical research.

Authors:  Sandra J Japuntich; Kimberly A Arditte Hall; Celina M Joos; Ann M Rasmusson; Suzanne L Pineles
Journal:  Int J Methods Psychiatr Res       Date:  2018-01-04       Impact factor: 4.035

2.  Emotional distress and tobacco demand during the menstrual cycle in female smokers.

Authors:  Samantha G Farris; Ana M Abrantes; Michael J Zvolensky
Journal:  Cogn Behav Ther       Date:  2018-07-31

Review 3.  Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?

Authors:  Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

4.  Examination of the stability of the anxiety sensitivity index across the menstrual cycle in trauma-exposed women with and without PTSD.

Authors:  Yael I Nillni; Kim A Arditte Hall; Kirsten J Langdon; Suzanne L Pineles
Journal:  Anxiety Stress Coping       Date:  2019-08-27

5.  Trauma Characteristics Moderate the Relation Between Estradiol and Trauma-Related Symptoms.

Authors:  Jenna K Rieder; Olena Kleshchova; Mariann R Weierich
Journal:  J Trauma Stress       Date:  2021-08-13

Review 6.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

Review 7.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285

Review 8.  Impact of Gender on Child and Adolescent PTSD.

Authors:  Kristie Garza; Tanja Jovanovic
Journal:  Curr Psychiatry Rep       Date:  2017-09-30       Impact factor: 5.285

Review 9.  Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder.

Authors:  Jessica R Peters; Tory A Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2019-10-17       Impact factor: 5.285

Review 10.  Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders.

Authors:  MacKenzie R Peltier; Terril L Verplaetse; Yann S Mineur; Ralitza Gueorguieva; Ismene Petrakis; Kelly P Cosgrove; Marina R Picciotto; Sherry A McKee
Journal:  Neuropharmacology       Date:  2021-02-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.